Anagrelide Hydrochloride: Potent PDE3 Inhibitor for Thrombocythemia Treatment & Research
Discover the key benefits and applications of Anagrelide Hydrochloride, a vital compound for hematological research.
Get a Quote & SampleProduct Core Value
Anagrelide Hydrochloride
Anagrelide hydrochloride is a highly pure compound known for its potent and selective inhibition of type III phosphodiesterase (PDE3). This mechanism is crucial for managing conditions characterized by excessive platelet production, such as essential thrombocythemia.
- Anagrelide hydrochloride for essential thrombocythemia is used to effectively lower platelet counts in patients, improving treatment outcomes.
- Leveraging its anagrelide hydrochloride mechanism of action, this chemical targets the pathways involved in megakaryocyte maturation.
- As a high-purity anagrelide hydrochloride pharmaceutical intermediate, it is ideal for drug synthesis and formulation development.
- Researchers can confidently buy anagrelide hydrochloride online for laboratory use, ensuring reliable results in their studies.
Advantages Offered
Targeted Inhibition
Anagrelide hydrochloride's ability to act as a potent PDE3 inhibitor makes it a valuable tool for studying platelet function and related cardiovascular conditions.
Clinical Relevance
Its established use in treating essential thrombocythemia highlights its significant role in managing myeloproliferative disorders, making it a key compound for pharmaceutical research.
Research Purity
With a purity of over 99% (HPLC), this anagrelide hydrochloride ensures accuracy and reproducibility in sensitive experimental setups.
Key Applications
Essential Thrombocythemia Management
Anagrelide hydrochloride is a cornerstone in the treatment of essential thrombocythemia, effectively controlling abnormally high platelet levels.
Platelet Aggregation Studies
Its well-defined anti-platelet aggregation properties make it an indispensable reagent for research into coagulation and thrombosis.
Pharmaceutical Drug Development
As a crucial pharmaceutical intermediate, anagrelide hydrochloride supports the development of novel therapies and generics in the pharmaceutical industry.
Biochemical Research
Researchers utilize anagrelide hydrochloride CAS 58579-51-4 to explore enzyme kinetics, particularly PDE3 inhibition, and its downstream effects in cellular pathways.